TrialInvestigational new drugs2012

Feasibility study of two schedules of sunitinib in combination with pemetrexed in patients with advanced solid tumors.

Isamu Okamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.